All terms
Saudi Food and Drug Authority
Saudi Arabian medical device regulator; central authority for the GCC reliance pathway.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed September 19, 2026
Definition
SFDA enforces the Medical Device Interim Regulation, requires Medical Device Marketing Authorisation (MDMA), and operates GHAD for device registration. It often relies on existing FDA, EU, Health Canada, TGA, or PMDA approvals for streamlined review. Saudi Arabia's Food and Drug Authority requires a Medical Device Marketing Authorization (MDMA) before devices are supplied, typically supported by approval in a reference jurisdiction such as the US, EU, Australia, Canada or Japan. Foreign manufacturers need an Authorized Representative in Saudi Arabia, devices must be listed in the national registry, and post-market obligations include incident reporting and field safety corrective actions. What the regulation says
The Saudi Food and Drug Authority (SFDA) regulates medical devices in Saudi Arabia, primarily through the Medical Device Interim Regulation. The SFDA emphasizes reliance on approvals from recognized international regulatory bodies like the FDA, EU notified bodies, Health Canada, the TGA, or PMDA to expedite the market authorization process. Device registration is managed through the SFDA's electronic platform, GHAD.What this means in practice
Increasingly important for global launch sequencing in the Middle East; reliance pathways meaningfully shorten timelines.Examples
- A manufacturer of Class II medical devices with FDA 510(k) clearance can leverage this approval for a streamlined Medical Device Marketing Authorisation (MDMA) submission to the SFDA.
- A company launching a new in vitro diagnostic (IVD) in Saudi Arabia will register the device and submit its marketing authorization application through the GHAD portal, including details of its CE Mark approval.
- An imaging equipment manufacturer seeking to enter the Saudi market will appoint a Saudi-based authorized representative to manage its SFDA interactions and device registrations.
Common pitfalls
- •A common pitfall is underestimating the specific documentation requirements for SFDA despite reliance pathways, as local representation and specific declarations are still needed.
- •Another mistake is assuming full reciprocity with other major regulators without understanding the SFDA's unique submission format and portal requirements.
- •Failing to maintain updated device registrations and marketing authorizations in GHAD can lead to compliance issues and market access disruptions.
- •Companies sometimes overlook the importance of local authorized representation, which is a mandatory requirement for medical device registration and vigilance in Saudi Arabia.
Frequently asked questions
GHAD is the Saudi Food and Drug Authority's (SFDA) electronic system used for registering medical devices, managing marketing authorizations, and handling other regulatory submissions. It is a critical platform for market access in Saudi Arabia.
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMore in Regulatory
· Same categoryRegulatory
510(k) Premarket Notification(510(k))
FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
Regulatory
510(k) Summary vs 510(k) Statement
Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.
Regulatory
513(g) Request for Information(513(g))
Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.
Regulatory
Abbreviated 510(k)
510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards.
Cited by
Where this term appears across MedTech Terms.
Ecosystems (1)
Latest in MedTech
Sources
3 sourcesEvery citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
Tier 2Regulator guidance and consensus· 3
Link health: 3 verified· last checked 2026-06-20
FDA·1European Commission·1IMDRF·1
- 1FDA - Medical DevicesTier 2 VerifiedFDAfda.gov
- 2European Commission - Medical DevicesTier 2 VerifiedEuropean Commissionhealth.ec.europa.eu
- 3IMDRF DocumentsTier 2 VerifiedIMDRFimdrf.org
Inline markers like [1] jump to the matching reference above.